{"entity":{"type":"insider","cik":"0001343124","url":"/insider/0001343124","json_url":"/insider/0001343124.json","name":"OBrien Christopher Flint","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":64,"n_filings":48,"first":"2008-10-01","last":"2018-02-07","span_basis":"filed_date"},"name_variants":[{"name":"OBrien Christopher Flint","source":"filing","n_filings":48,"first_seen":"2008-10-01","last_seen":"2018-02-07"}],"transactions":[{"id":6720485,"accession":"0001209191-18-008219","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-008219","line_url":"/filing/0001209191-18-008219","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Former Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Former Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Former Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2613.0,"shares_display":"2,613","price_per_share":83.1769858783008,"price_display":"83.18","price_state":"stated","total_value":217341.4641,"total_display":"217,341.46","total_whole":"217,341","shares_owned_after":52223.0,"shares_owned_after_display":"52,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider","n_lines":2},{"id":6720255,"accession":"0001209191-18-004246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-004246","line_url":"/filing/0001209191-18-004246#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":79.1423,"price_display":"79.14","price_state":"stated","total_value":138499.025,"total_display":"138,499.02","total_whole":"138,499","shares_owned_after":50723.0,"shares_owned_after_display":"50,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider"},{"id":4542792,"accession":"0001209191-17-059434","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-059434","line_url":"/filing/0001209191-17-059434","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52817.0,"shares_display":"52,817","price_per_share":69.7056,"price_display":"69.71","price_state":"stated","total_value":3681640.6752,"total_display":"3,681,640.68","total_whole":"3,681,641","shares_owned_after":48973.0,"shares_owned_after_display":"48,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-06","scope":"insider","n_lines":2},{"id":4945651,"accession":"0001209191-17-055457","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-055457","line_url":"/filing/0001209191-17-055457#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6925.0,"shares_display":"6,925","price_per_share":61.04,"price_display":"61.04","price_state":"stated","total_value":422702.0,"total_display":"422,702.00","total_whole":"422,702","shares_owned_after":48973.0,"shares_owned_after_display":"48,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-03","scope":"insider"},{"id":4906988,"accession":"0001209191-17-051944","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-051944","line_url":"/filing/0001209191-17-051944#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52817.0,"shares_display":"52,817","price_per_share":57.5,"price_display":"57.50","price_state":"stated","total_value":3036977.5,"total_display":"3,036,977.50","total_whole":"3,036,978","shares_owned_after":48973.0,"shares_owned_after_display":"48,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-05","filed_date":"2017-09-07","scope":"insider"},{"id":5319927,"accession":"0001209191-17-046685","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-046685","line_url":"/filing/0001209191-17-046685#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8734.0,"shares_display":"8,734","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":436700.0,"total_display":"436,700.00","total_whole":"436,700","shares_owned_after":48973.0,"shares_owned_after_display":"48,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-27","filed_date":"2017-07-31","scope":"insider"},{"id":4783037,"accession":"0001209191-17-034638","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-034638","line_url":"/filing/0001209191-17-034638#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105634.0,"shares_display":"105,634","price_per_share":53.32,"price_display":"53.32","price_state":"stated","total_value":5632404.88,"total_display":"5,632,404.88","total_whole":"5,632,405","shares_owned_after":48973.0,"shares_owned_after_display":"48,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-18","filed_date":"2017-05-23","scope":"insider"},{"id":5173013,"accession":"0001209191-17-026884","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-026884","line_url":"/filing/0001209191-17-026884","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13065.0,"shares_display":"13,065","price_per_share":50.422803673938,"price_display":"50.42","price_state":"stated","total_value":658773.93,"total_display":"658,773.93","total_whole":"658,774","shares_owned_after":49177.0,"shares_owned_after_display":"49,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-12","filed_date":"2017-04-13","scope":"insider","n_lines":2},{"id":4859687,"accession":"0001209191-17-008912","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-008912","line_url":"/filing/0001209191-17-008912#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1206.0,"shares_display":"1,206","price_per_share":43.17,"price_display":"43.17","price_state":"stated","total_value":52063.02,"total_display":"52,063.02","total_whole":"52,063","shares_owned_after":37038.0,"shares_owned_after_display":"37,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-08","scope":"insider"},{"id":4706480,"accession":"0001209191-17-008131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-008131","line_url":"/filing/0001209191-17-008131#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":42.5,"price_display":"42.50","price_state":"stated","total_value":63750.0,"total_display":"63,750.00","total_whole":"63,750","shares_owned_after":35044.0,"shares_owned_after_display":"35,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-03","filed_date":"2017-02-06","scope":"insider"},{"id":4732440,"accession":"0001209191-17-004301","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-004301","line_url":"/filing/0001209191-17-004301#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":40.66,"price_display":"40.66","price_state":"stated","total_value":71155.0,"total_display":"71,155.00","total_whole":"71,155","shares_owned_after":33544.0,"shares_owned_after_display":"33,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-18","scope":"insider"},{"id":5278006,"accession":"0001209191-17-003588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-003588","line_url":"/filing/0001209191-17-003588#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":43.35,"price_display":"43.35","price_state":"stated","total_value":75862.5,"total_display":"75,862.50","total_whole":"75,863","shares_owned_after":31794.0,"shares_owned_after_display":"31,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-10","filed_date":"2017-01-12","scope":"insider"},{"id":3046264,"accession":"0001209191-16-150474","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-150474","line_url":"/filing/0001209191-16-150474#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":52.84,"price_display":"52.84","price_state":"stated","total_value":1321000.0,"total_display":"1,321,000.00","total_whole":"1,321,000","shares_owned_after":30044.0,"shares_owned_after_display":"30,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-15","filed_date":"2016-11-16","scope":"insider"},{"id":2131270,"accession":"0001209191-16-137340","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-137340","line_url":"/filing/0001209191-16-137340#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":48.73,"price_display":"48.73","price_state":"stated","total_value":609125.0,"total_display":"609,125.00","total_whole":"609,125","shares_owned_after":55044.0,"shares_owned_after_display":"55,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-16","scope":"insider"},{"id":2665944,"accession":"0001209191-16-125032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-125032","line_url":"/filing/0001209191-16-125032#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":625000.0,"total_display":"625,000.00","total_whole":"625,000","shares_owned_after":67544.0,"shares_owned_after_display":"67,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-02","scope":"insider"},{"id":2469564,"accession":"0001209191-16-121450","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-121450","line_url":"/filing/0001209191-16-121450#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":1125000.0,"total_display":"1,125,000.00","total_whole":"1,125,000","shares_owned_after":80044.0,"shares_owned_after_display":"80,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-18","scope":"insider"},{"id":2884893,"accession":"0001209191-16-113771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-113771","line_url":"/filing/0001209191-16-113771#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":1125000.0,"total_display":"1,125,000.00","total_whole":"1,125,000","shares_owned_after":105044.0,"shares_owned_after_display":"105,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-06","filed_date":"2016-04-08","scope":"insider"},{"id":3077801,"accession":"0001209191-16-095852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-095852","line_url":"/filing/0001209191-16-095852#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":38.01,"price_display":"38.01","price_state":"stated","total_value":57015.0,"total_display":"57,015.00","total_whole":"57,015","shares_owned_after":130044.0,"shares_owned_after_display":"130,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-03","filed_date":"2016-02-04","scope":"insider"},{"id":3345253,"accession":"0001209191-16-092889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-092889","line_url":"/filing/0001209191-16-092889#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":46.77,"price_display":"46.77","price_state":"stated","total_value":81847.5,"total_display":"81,847.50","total_whole":"81,848","shares_owned_after":128544.0,"shares_owned_after_display":"128,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-19","filed_date":"2016-01-21","scope":"insider"},{"id":3197729,"accession":"0001209191-16-091256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-091256","line_url":"/filing/0001209191-16-091256#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":44.25,"price_display":"44.25","price_state":"stated","total_value":77437.5,"total_display":"77,437.50","total_whole":"77,438","shares_owned_after":126794.0,"shares_owned_after_display":"126,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-13","scope":"insider"},{"id":8786361,"accession":"0001209191-15-076201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-076201","line_url":"/filing/0001209191-15-076201#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":47.78,"price_display":"47.78","price_state":"stated","total_value":1194500.0,"total_display":"1,194,500.00","total_whole":"1,194,500","shares_owned_after":125044.0,"shares_owned_after_display":"125,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-16","filed_date":"2015-10-19","scope":"insider"},{"id":8300799,"accession":"0001209191-15-061952","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-061952","line_url":"/filing/0001209191-15-061952#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11250.0,"shares_display":"11,250","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":618750.0,"total_display":"618,750.00","total_whole":"618,750","shares_owned_after":100044.0,"shares_owned_after_display":"100,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-20","filed_date":"2015-07-21","scope":"insider"},{"id":8886161,"accession":"0001209191-15-060835","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-060835","line_url":"/filing/0001209191-15-060835#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":100044.0,"shares_owned_after_display":"100,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-13","filed_date":"2015-07-14","scope":"insider"},{"id":8925897,"accession":"0001209191-15-051983","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-051983","line_url":"/filing/0001209191-15-051983#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":100044.0,"shares_owned_after_display":"100,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-10","scope":"insider"},{"id":8374110,"accession":"0001209191-15-049732","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-049732","line_url":"/filing/0001209191-15-049732#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":42.2,"price_display":"42.20","price_state":"stated","total_value":422000.0,"total_display":"422,000.00","total_whole":"422,000","shares_owned_after":100044.0,"shares_owned_after_display":"100,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-03","scope":"insider"},{"id":8392469,"accession":"0000914475-15-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-15-000047","line_url":"/filing/0000914475-15-000047#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":30.79,"price_display":"30.79","price_state":"stated","total_value":53882.5,"total_display":"53,882.50","total_whole":"53,883","shares_owned_after":100044.0,"shares_owned_after_display":"100,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-21","scope":"insider"},{"id":8075625,"accession":"0000914475-15-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-15-000031","line_url":"/filing/0000914475-15-000031#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":28.41,"price_display":"28.41","price_state":"stated","total_value":49717.5,"total_display":"49,717.50","total_whole":"49,718","shares_owned_after":98294.0,"shares_owned_after_display":"98,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-13","scope":"insider"},{"id":8593984,"accession":"0000914475-15-000014","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000914475-15-000014","line_url":"/filing/0000914475-15-000014","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":27.216363636363635,"price_display":"27.22","price_state":"stated","total_value":1496900.0,"total_display":"1,496,900.00","total_whole":"1,496,900","shares_owned_after":96544.0,"shares_owned_after_display":"96,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-09","scope":"insider","n_lines":3},{"id":6532752,"accession":"0001209191-14-077175","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-077175","line_url":"/filing/0001209191-14-077175#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":24.02,"price_display":"24.02","price_state":"stated","total_value":480400.0,"total_display":"480,400.00","total_whole":"480,400","shares_owned_after":95644.0,"shares_owned_after_display":"95,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-19","filed_date":"2014-12-19","scope":"insider"},{"id":6891729,"accession":"0000914475-14-000084","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000914475-14-000084","line_url":"/filing/0000914475-14-000084","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19875.0,"shares_display":"19,875","price_per_share":22.1,"price_display":"22.10","price_state":"stated","total_value":439237.5,"total_display":"439,237.50","total_whole":"439,238","shares_owned_after":96544.0,"shares_owned_after_display":"96,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-12","scope":"insider","n_lines":2},{"id":6891713,"accession":"0000914475-14-000084","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-14-000084","line_url":"/filing/0000914475-14-000084","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20125.0,"shares_display":"20,125","price_per_share":21.5527950310559,"price_display":"21.55","price_state":"stated","total_value":433750.0,"total_display":"433,750.00","total_whole":"433,750","shares_owned_after":96544.0,"shares_owned_after_display":"96,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-12","scope":"insider","n_lines":2},{"id":6236979,"accession":"0001209191-14-071193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-071193","line_url":"/filing/0001209191-14-071193#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5463.0,"shares_display":"5,463","price_per_share":19.53,"price_display":"19.53","price_state":"stated","total_value":106692.39,"total_display":"106,692.39","total_whole":"106,692","shares_owned_after":96544.0,"shares_owned_after_display":"96,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-25","scope":"insider"},{"id":6453514,"accession":"0000914475-14-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-14-000078","line_url":"/filing/0000914475-14-000078#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11300.0,"shares_display":"11,300","price_per_share":19.51,"price_display":"19.51","price_state":"stated","total_value":220463.0,"total_display":"220,463.00","total_whole":"220,463","shares_owned_after":96544.0,"shares_owned_after_display":"96,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-17","filed_date":"2014-11-19","scope":"insider"},{"id":7062471,"accession":"0000914475-14-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-14-000076","line_url":"/filing/0000914475-14-000076#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3237.0,"shares_display":"3,237","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":63121.5,"total_display":"63,121.50","total_whole":"63,122","shares_owned_after":96544.0,"shares_owned_after_display":"96,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-17","scope":"insider"},{"id":6453511,"accession":"0000914475-14-000074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-14-000074","line_url":"/filing/0000914475-14-000074#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":18.62,"price_display":"18.62","price_state":"stated","total_value":372400.0,"total_display":"372,400.00","total_whole":"372,400","shares_owned_after":96544.0,"shares_owned_after_display":"96,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-10","filed_date":"2014-11-12","scope":"insider"},{"id":6598076,"accession":"0000914475-14-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-14-000020","line_url":"/filing/0000914475-14-000020","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6750.0,"shares_display":"6,750","price_per_share":18.883333333333333,"price_display":"18.88","price_state":"stated","total_value":127462.5,"total_display":"127,462.50","total_whole":"127,463","shares_owned_after":94794.0,"shares_owned_after_display":"94,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-10","filed_date":"2014-01-13","scope":"insider","n_lines":2},{"id":6305424,"accession":"0000914475-14-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-14-000008","line_url":"/filing/0000914475-14-000008#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":87500.0,"total_display":"87,500.00","total_whole":"87,500","shares_owned_after":94794.0,"shares_owned_after_display":"94,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-07","filed_date":"2014-01-08","scope":"insider"},{"id":5380631,"accession":"0000914475-13-000074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-13-000074","line_url":"/filing/0000914475-13-000074#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":94794.0,"shares_owned_after_display":"94,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-03","filed_date":"2013-09-05","scope":"insider"},{"id":4854017,"accession":"0000914475-13-000065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-13-000065","line_url":"/filing/0000914475-13-000065#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":94794.0,"shares_owned_after_display":"94,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-05","filed_date":"2013-08-07","scope":"insider"},{"id":5403253,"accession":"0000914475-13-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-13-000053","line_url":"/filing/0000914475-13-000053#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.5,"price_display":"14.50","price_state":"stated","total_value":72500.0,"total_display":"72,500.00","total_whole":"72,500","shares_owned_after":94794.0,"shares_owned_after_display":"94,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-12","filed_date":"2013-07-16","scope":"insider"},{"id":5521616,"accession":"0000914475-13-000051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-13-000051","line_url":"/filing/0000914475-13-000051#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":101250.0,"total_display":"101,250.00","total_whole":"101,250","shares_owned_after":94794.0,"shares_owned_after_display":"94,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-28","filed_date":"2013-07-01","scope":"insider"},{"id":5521613,"accession":"0000914475-13-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-13-000051","line_url":"/filing/0000914475-13-000051#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001343124","owner_name":"OBrien Christopher Flint","owner_display_name":"OBrien Christopher Flint","owner_url":"/insider/0001343124","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3857.0,"shares_display":"3,857","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":50141.0,"total_display":"50,141.00","total_whole":"50,141","shares_owned_after":94794.0,"shares_owned_after_display":"94,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-27","filed_date":"2013-07-01","scope":"insider"}],"collapsed":true,"next_cursor":"2013-06-27|5521613","ledger_fault":false,"count":{"value":64,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":64,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":64},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000914475","name":"NEUROCRINE BIOSCIENCES INC","url":"/issuer/0000914475","role":"Officer (Former Chief Medical Officer)","n_filings":48,"first_seen":"2008-10-01","last_seen":"2018-02-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001343124","retrieved_at":"2026-08-25T15:37:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}